Viewing nowSitagliptin Phosphate Hydrate 25 mg Tablet
Sitagliptin Phosphate Hydrate 32.125mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

MFDS item code 201503507 · Approved 2015.05.29 · Insurance code 643307060
Improvement of glycemic control in patients with type 2 diabetes mellitus
This medication is used in conjunction with diet and exercise to help control blood sugar in patients with type 2 diabetes. It can be used alone, but if blood sugar control is difficult, it may be administered in combination with metformin, sulfonylureas, thiazolidinediones, or insulin. In particular, if existing diabetes treatments do not provide sufficient effect, this medication can be added to enhance treatment efficacy. It helps improve blood sugar control when used with various medications. Overall, it is used to effectively improve blood sugar management in type 2 diabetes.
Whether used as monotherapy or in combination therapy, administer 100 mg once daily; the maximum daily dose is 100 mg. This medicine may be taken with or without food. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia caused by the sulfonylurea or insulin (see Precautions for Use, 5. General Precautions). Patients with renal impairment Since dosage adjustment is required according to renal function, assessment of renal function is recommended before treatment with this medicine and periodically thereafter. 1. No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is necessary in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45mL/min/1.73 m2 and < 60mL/min/1.73 m2). 3. In patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30mL/min/1.73 m2 and < 45mL/min/1.73 m2), administer 50 mg once daily. 4. In patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15mL/min/1.73 m2 and < 30mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2), administer 25 mg once daily. This medicine may be administered regardless of the timing of dialysis.
This medication can cause severe allergic reactions, so if symptoms such as rash, difficulty breathing, or swelling of the face or neck appear after taking the medication, you must immediately stop taking it and consult a doctor. In addition, acute pancreatitis, a serious inflammation of the pancreas, may occur; therefore, if abdominal pain, vomiting, or persistent discomfort in the abdomen occurs, quickly inform medical personnel. This medication should not be used in patients with type 1 diabetes or diabetic ketoacidosis, nor should it be taken by individuals with an allergy to the active ingredient. Patients with impaired renal function may have delayed excretion of this medication, so dosage adjustments should be made cautiously. During treatment, side effects such as cold symptoms, headaches, indigestion, and diarrhea may occur, and especially when taken with other blood sugar-lowering agents, hypoglycemia symptoms may occur more frequently. Hypoglycemia symptoms include dizziness, cold sweat, and severe fatigue, so caution is needed. This medication can also be used in the elderly, but regular kidney function tests should be conducted, and pregnant or breastfeeding women are advised not to take it. In case of overdose, general treatment should be conducted along with monitoring the heart condition, and if necessary, dialysis may be performed to remove the medication. Rare side effects such as joint pain or skin diseases may develop during long-term use, so inform a doctor if any unusual symptoms occur. Finally, there are minimal special interactions when used in combination with other medications, but it is important to consult medical personnel if taking specific medications.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air or moisture from entering, and it is best to store it at room temperature between 1 and 30 degrees Celsius. By doing so, the effectiveness of the medication can be maintained and deterioration can be prevented.
Pink-colored round film-coated tablet
PTP - 30 tablets/box [(10 tablets/PTP x 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSitagliptin Phosphate Hydrate 32.125mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Sitagliptin Phosphate Hydrate 64.25mg
Tablet · Prescription medication
Jongkeundang Co., Ltd.

Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Sitagliptin Phosphate Hydrate 32.13mg
Tablet · Prescription medication
Jong Kundang Co., Ltd.
Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.
Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication
Vivozon Pharmaceutical Co., Ltd.
Sitagliptin Phosphate Hydrate 64.25mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.
Sitagliptin Phosphate Hydrate 32.125mg
Tablet · Prescription medication
Sinpoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.